Douglas Kerr - Chief Medical Officer at Dyne Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
DYN on Nasdaq
All Insider Reports
All Insider Reports

Douglas Kerr - trading volume in the past year for Dyne Therapeutics, Inc.

Holdings reported by Douglas Kerr for Dyne Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 171,606 $2,556,929 $14.90 05 Mar 2026 Direct
Stock option (right to buy) 130,000 12 Feb 2026 Direct Common Stock

Transactions reported by Douglas Kerr for Dyne Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.